Investigates the influence of patient capital on green innovation in resource-based enterprises, highlighting important mechanisms and implications.
Against the background of China’s “dual carbon” goals and the continued advancement of the green and low-carbon transformation of resource-based industries, resource-based enterprises urgently need to rely on green innovation to overcome development constraints characterized by high resource dependence, strong environmental pressures, and mounting transformation challenges. Patient capital, with its long-term orientation, stable support, and risk-sharing characteristics, can provide sustained financial backing and governance support for green innovation in resource-based enterprises; however, its underlying mechanism remains to be further explored. Drawing on patient capital theory, this study constructs a “capital–ESG–innovation” analytical framework to examine the impact of patient capital on green innovation in resource-based enterprises and its mechanism of action. Using Chinese A-share listed resource-based enterprises from 2014 to 2023 as the research sample, this study measures patient capital from two dimensions, namely stable equity and relational debt, and conducts empirical analysis through panel regression and multiple robustness tests. The results show that patient capital significantly promotes green innovation in resource-based enterprises, with both relational debt and stable equity playing positive roles. Mechanism tests reveal that ESG performance serves as an important mediating channel through which patient capital promotes green innovation. Further analysis indicates that the level of regional marketization strengthens the green innovation effect of patient capital, and this effect is more pronounced in large enterprises, enterprises subject to stronger media supervision, and enterprises whose executives have higher green cognition. This study enriches the literature on the relationship between patient capital and green innovation and provides empirical evidence for cultivating long-term capital and promoting the green and low-carbon transformation of resource-based enterprises.
No takes yet. Share an insight, caveat, or question.
Ju et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: